Boston Scientific Corp

詳細情報 Boston Scientific Corp 企業名

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. Its MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. Its Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions. It also owns the transcarotid artery revascularization (TCAR) platform.

企業情報

企業コードBSX

会社名Boston Scientific Corp

上場日May 19, 1992

最高経営責任者「CEO」Mr. Michael F. (Mike) Mahoney

従業員数53000

証券種類Ordinary Share

決算期末May 19

本社所在地300 Boston Scientific Way

都市MARLBOROUGH

証券取引所NYSE Consolidated

国United States of America

郵便番号01752-1234

電話番号15086834000

ウェブサイトhttps://www.bostonscientific.com/en-US/Home.html

企業コードBSX

上場日May 19, 1992

最高経営責任者「CEO」Mr. Michael F. (Mike) Mahoney

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.75M

-3.25%

Mr. John E. Sununu

Independent Director

54.72K

+3.95%

Mr. David S. (Dave) Wichmann

Independent Director

41.58K

+5.27%

Ms. Ellen M. Zane

Independent Director

37.02K

+5.96%

Mr. Jonathan R. Monson

Chief Financial Officer, Executive Vice President

35.29K

+1.62%

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

33.45K

+6.64%

Mr. David C. Habiger

Independent Director

5.63K

+58.67%

Mr. Yoshiaki Fujimori

Independent Director

2.08K

-58.23%

Mr. Arthur Crosswell Butcher

Executive Vice President, Group President, MedSurg and Asia Pacific

--

Mr. Edward J. Ludwig

Lead Independent Director

--

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.75M

-3.25%

Mr. John E. Sununu

Independent Director

54.72K

+3.95%

Mr. David S. (Dave) Wichmann

Independent Director

41.58K

+5.27%

Ms. Ellen M. Zane

Independent Director

37.02K

+5.96%

Mr. Jonathan R. Monson

Chief Financial Officer, Executive Vice President

35.29K

+1.62%

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

33.45K

+6.64%

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Electrophysiology

730.00M

15.66%

Interventional Cardiology Therapies

697.00M

14.95%

Endoscopy

673.00M

14.43%

Peripheral Interventions

656.00M

14.07%

Urology

633.00M

13.57%

Other

1.27B

27.32%

地域別USD

会社名

収益

比率

United States

2.96B

63.48%

EMEA (Europe, Middle East and Africa)

846.00M

18.14%

Asia Pacific

701.00M

15.03%

Latin America and Canada

155.00M

3.32%

事業別

地域別

事業別USD

会社名

収益

比率

Electrophysiology

730.00M

15.66%

Interventional Cardiology Therapies

697.00M

14.95%

Endoscopy

673.00M

14.43%

Peripheral Interventions

656.00M

14.07%

Urology

633.00M

13.57%

Other

1.27B

27.32%

株主

更新時刻: 56 minutes ago

株主統計

種類

株主統計

比率

The Vanguard Group, Inc.

9.21%

Fidelity Management & Research Company LLC

7.93%

BlackRock Institutional Trust Company, N.A.

5.28%

State Street Global Advisors (US)

4.35%

PRIMECAP Management Company

2.34%

Other

70.90%

株主統計

比率

The Vanguard Group, Inc.

9.21%

Fidelity Management & Research Company LLC

7.93%

BlackRock Institutional Trust Company, N.A.

5.28%

State Street Global Advisors (US)

4.35%

PRIMECAP Management Company

2.34%

Other

70.90%

種類

株主統計

比率

Investment Advisor

52.34%

Investment Advisor/Hedge Fund

28.00%

Hedge Fund

3.97%

Pension Fund

2.90%

Research Firm

2.43%

Bank and Trust

1.73%

Sovereign Wealth Fund

1.53%

Family Office

0.22%

Private Equity

0.20%

Other

6.68%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

2752

1.39B

93.57%

+165.36K

2025Q1

2744

1.39B

93.81%

-5.31M

2024Q4

2559

1.38B

93.61%

+1.09M

2024Q3

2417

1.37B

92.76%

-24.32M

2024Q2

2341

1.37B

93.29%

-18.17M

2024Q1

2227

1.37B

93.23%

-40.14M

2023Q4

2171

1.39B

94.95%

-25.34M

2023Q3

2110

1.39B

95.17%

-6.29M

2023Q2

2081

1.38B

95.67%

-15.63M

2023Q1

2012

1.36B

94.85%

-23.81M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

The Vanguard Group, Inc.

133.95M

9.05%

+1.70M

+1.28%

Mar 31, 2025

Fidelity Management & Research Company LLC

117.45M

7.94%

-3.75M

-3.09%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

77.81M

5.26%

+1.08M

+1.41%

Mar 31, 2025

State Street Global Advisors (US)

64.48M

4.36%

+514.79K

+0.80%

Mar 31, 2025

PRIMECAP Management Company

36.50M

2.47%

-432.72K

-1.17%

Mar 31, 2025

Wellington Management Company, LLP

33.20M

2.24%

-2.97M

-8.21%

Mar 31, 2025

Geode Capital Management, L.L.C.

31.80M

2.15%

+1.18M

+3.84%

Mar 31, 2025

Capital World Investors

28.56M

1.93%

+658.82K

+2.36%

Mar 31, 2025

Managed Account Advisors LLC

21.29M

1.44%

+3.60M

+20.36%

Mar 31, 2025

The Bollard Group, LLC

20.49M

1.39%

-242.40K

-1.17%

Mar 31, 2025

詳細を見る

102.550USD

Boston Scientific Corp

102.550

概要

企業名

金融